Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kashimshetty, Rohini | - |
dc.contributor.author | Desai, Varsha G. | - |
dc.contributor.author | Kate, Vijay M. | - |
dc.contributor.author | Lee, Taewon | - |
dc.contributor.author | Moland, Carrie L. | - |
dc.contributor.author | Branham, William S. | - |
dc.contributor.author | New, Lee S. | - |
dc.contributor.author | Chan, Eric C. Y. | - |
dc.contributor.author | Younis, Husam | - |
dc.contributor.author | Boelsterli, Urs A. | - |
dc.date.accessioned | 2021-09-08T15:28:45Z | - |
dc.date.available | 2021-09-08T15:28:45Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2009-07-15 | - |
dc.identifier.issn | 0041-008X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/119664 | - |
dc.description.abstract | Flutamide, a widely used nonsteroidal anti-androgen, but not its bioisostere bicalutamide, has been associated with idiosyncratic drug-induced liver injury. Although the susceptibility factors are unknown, mitochondrial injury has emerged as a putative hazard of flutamide. To explore the role of mitochondrial sensitization in flutamide hepatotoxicity, we determined the effects of superimposed drug stress in a murine model of underlying mitochondrial abnormalities. Male wild-type or heterozygous Sod2(+/-) mice were injected intraperitoneously with flutamide (0, 30 or 100 mg/kg/day) for 28 days. A kinetic pilot study revealed that flutamide (100 mg/kg/day) caused approximately 10-fold greater exposure than the reported therapeutic mean plasma levels. Mutant (5/10), but not wild-type, mice in the high-dose group exhibited small foci of hepatocellular necrosis and an increased number of apoptotic hepatocytes. Hepatic GSSG/GSH, protein carbonyl levels, and serum lactate levels were significantly increased, suggesting oxidant stress and mitochondrial dysfunction. Measurement of mitochondrial superoxide in cultured hepatocytes demonstrated that mitochondria were a significant source of flutamide-enhanced oxidant stress. Indeed, mitochondria isolated from flutamide-treated Sod2(+/-) mice exhibited decreased aconitase activity as compared to vehicle controls. A transcriptomics analysis using MitoChips revealed that flutamide-treated Sod2(+/-) mice exhibited a selective decrease in the expression of all complexes I and III subunits encoded by mitochondrial DNA. In contrast, Sod2(+/-) mice receiving bicalutamide (50 mg/kg/day) did not reveal any hepatic changes. These results are compatible with our concept that flutamide targets hepatic mitochondria and exerts oxidant stress that can lead to overt hepatic injury in the presence of an underlying mitochondrial abnormality. (C) 2009 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.subject | HETEROZYGOUS SOD2(+/-) MICE | - |
dc.subject | IN-VITRO | - |
dc.subject | SUPEROXIDE-DISMUTASE | - |
dc.subject | PROSTATE-CANCER | - |
dc.subject | ANIMAL-MODEL | - |
dc.subject | CYANO ANALOG | - |
dc.subject | HEPATOTOXICITY | - |
dc.subject | METABOLITES | - |
dc.subject | BIOACTIVATION | - |
dc.subject | MICROSOMES | - |
dc.title | Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Taewon | - |
dc.identifier.doi | 10.1016/j.taap.2009.05.007 | - |
dc.identifier.scopusid | 2-s2.0-67349231918 | - |
dc.identifier.wosid | 000267584200006 | - |
dc.identifier.bibliographicCitation | TOXICOLOGY AND APPLIED PHARMACOLOGY, v.238, no.2, pp.150 - 159 | - |
dc.relation.isPartOf | TOXICOLOGY AND APPLIED PHARMACOLOGY | - |
dc.citation.title | TOXICOLOGY AND APPLIED PHARMACOLOGY | - |
dc.citation.volume | 238 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 150 | - |
dc.citation.endPage | 159 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | HETEROZYGOUS SOD2(+/-) MICE | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | SUPEROXIDE-DISMUTASE | - |
dc.subject.keywordPlus | PROSTATE-CANCER | - |
dc.subject.keywordPlus | ANIMAL-MODEL | - |
dc.subject.keywordPlus | CYANO ANALOG | - |
dc.subject.keywordPlus | HEPATOTOXICITY | - |
dc.subject.keywordPlus | METABOLITES | - |
dc.subject.keywordPlus | BIOACTIVATION | - |
dc.subject.keywordPlus | MICROSOMES | - |
dc.subject.keywordAuthor | Flutamide | - |
dc.subject.keywordAuthor | Drug-induced liver injury (DILI) | - |
dc.subject.keywordAuthor | Superoxide dismutase | - |
dc.subject.keywordAuthor | Sod2(+/-) mice | - |
dc.subject.keywordAuthor | Hepatotoxicity | - |
dc.subject.keywordAuthor | Mitochondria | - |
dc.subject.keywordAuthor | Idiosyncratic drug toxicity | - |
dc.subject.keywordAuthor | Bicalutamide | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.